Paranasal Sinus Cancer
📧 Sign up to get email alerts when something new happens for Paranasal Sinus Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-10-18Clinical Trial Update: A Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal Passages [Phase 2]
A Phase 2 trial evaluating endoscopic surgery followed by chemotherapy and proton radiation for paranasal sinus cancers and nasal cavity tum…
-
CLINICAL_TRIALS trial_result · 2021-11-10Clinical Trial Update: Camrelizumab Plus Chemoradiotherapy for Patients With Locoregional Cancer of Nasal Cavity and Paranasal Sinuses [Phase 2]
Phase 2 trial evaluating camrelizumab in combination with chemoradiotherapy for locoregional nasal cavity and paranasal sinus cancers.
-
CLINICAL_TRIALS trial_result · 2021-10-26Clinical Trial Update: Adaptive Radiotherapy for Head and Neck Cancer [Phase 2]
Phase 2 trial update on adaptive radiotherapy for head and neck cancers completed.
-
CLINICAL_TRIALS trial_result · 2018-03-13Clinical Trial Update: Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer [Phase 2]
Phase 2 clinical trial evaluating fluorouracil, hydroxyurea, cetuximab with twice-daily intensity-modulated radiation therapy for advanced h…
-
CLINICAL_TRIALS trial_result · 2017-08-14Clinical Trial Update: Photon/Proton Radiation Therapy for Cancers of the Nasal Cavity and/or Paranasal Sinuses
A completed clinical trial evaluated photon/proton radiation therapy for cancers of the nasal cavity and paranasal sinuses.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 2]
Phase 2 trial examining cisplatin with or without the WEE1 inhibitor MK-1775 in recurrent or metastatic head and neck cancers was terminated…
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating the combination of erlotinib and celecoxib with reirradiation in recurrent head and neck cancer; results posted i…
-
CLINICAL_TRIALS trial_result · 2012-07-27Clinical Trial Update: Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 2]
A Phase 2 study of dasatinib in patients with recurrent or metastatic head and neck cancer has completed and posted results.